Your browser is no longer supported. Please, upgrade your browser.
Apollo Endosurgery, Inc.
Index- P/E- EPS (ttm)-0.72 Insider Own6.40% Shs Outstand26.31M Perf Week3.72%
Market Cap198.69M Forward P/E- EPS next Y-0.75 Insider Trans8.18% Shs Float20.02M Perf Month-0.12%
Income-17.00M PEG- EPS next Q-0.20 Inst Own58.30% Short Float0.63% Perf Quarter44.72%
Sales45.20M P/S4.40 EPS this Y22.00% Inst Trans5.93% Short Ratio1.03 Perf Half Y94.00%
Book/sh0.10 P/B80.90 EPS next Y2.60% ROA-23.20% Target Price12.33 Perf Year408.81%
Cash/sh1.29 P/C6.27 EPS next 5Y- ROE-730.70% 52W Range1.25 - 9.01 Perf YTD137.94%
Dividend- P/FCF- EPS past 5Y63.40% ROI-24.90% 52W High-10.21% Beta2.18
Dividend %- Quick Ratio3.60 Sales past 5Y-9.10% Gross Margin53.40% 52W Low547.20% ATR0.46
Employees158 Current Ratio4.40 Sales Q/Q29.90% Oper. Margin-28.50% RSI (14)52.68 Volatility7.58% 5.80%
OptionableYes Debt/Eq21.30 EPS Q/Q64.00% Profit Margin-37.50% Rel Volume0.51 Prev Close7.35
ShortableYes LT Debt/Eq20.89 EarningsMay 04 AMC Payout- Avg Volume122.71K Price8.09
Recom2.00 SMA201.84% SMA502.27% SMA20054.43% Volume62,790 Change10.07%
May-17-21Initiated Lake Street Buy $12
Apr-28-20Downgrade Piper Sandler Overweight → Neutral $4.50 → $2
Jan-02-19Upgrade Northland Capital Under Perform → Market Perform
Nov-09-18Downgrade Northland Capital Market Perform → Under Perform
Aug-09-18Downgrade Northland Capital Outperform → Market Perform
Jan-04-18Resumed ROTH Capital Buy $9.50
Sep-26-17Initiated Northland Capital Outperform $12
Aug-02-17Initiated ROTH Capital Buy $10
Jul-27-21 03:02PM  
Jul-16-21 07:00AM  
Jun-20-21 03:30AM  
Jun-14-21 07:30AM  
Jun-01-21 12:00PM  
May-24-21 07:00AM  
May-18-21 05:30PM  
May-12-21 04:05PM  
May-06-21 01:59AM  
May-04-21 07:25PM  
May-03-21 08:02AM  
Apr-28-21 08:00AM  
Apr-26-21 12:31PM  
Apr-21-21 04:15PM  
Mar-22-21 01:24AM  
Mar-19-21 08:00AM  
Mar-08-21 07:30AM  
Mar-03-21 08:00AM  
Mar-01-21 06:30AM  
Feb-25-21 04:01PM  
Feb-24-21 10:23AM  
Feb-22-21 04:30PM  
Feb-08-21 09:15AM  
Feb-05-21 12:21AM  
Jan-05-21 04:05PM  
Dec-15-20 04:00PM  
Dec-07-20 08:30AM  
Dec-02-20 10:59AM  
Nov-23-20 11:40AM  
Nov-19-20 06:45AM  
Nov-07-20 07:36AM  
Nov-05-20 04:01PM  
Nov-03-20 08:00AM  
Oct-29-20 04:40PM  
Oct-20-20 06:56AM  
Oct-01-20 04:05PM  
Sep-11-20 03:00PM  
Sep-01-20 07:01PM  
Aug-31-20 06:05PM  
Aug-26-20 10:30AM  
Aug-05-20 09:00AM  
Aug-04-20 04:01PM  
Jul-30-20 04:05PM  
Jul-20-20 06:30AM  
Jul-13-20 01:36PM  
Jul-07-20 07:30AM  
Jun-10-20 04:01PM  
May-04-20 04:01PM  
Apr-30-20 04:15PM  
Apr-14-20 09:13AM  
Apr-13-20 09:00AM  
Mar-31-20 08:27AM  
Mar-28-20 08:57AM  
Mar-26-20 04:00PM  
Mar-24-20 04:30PM  
Feb-13-20 05:52AM  
Dec-30-19 08:41AM  
Dec-22-19 01:52PM  
Dec-12-19 02:30PM  
Dec-02-19 08:00AM  
Nov-25-19 08:00AM  
Nov-12-19 05:42AM  
Nov-04-19 08:00AM  
Oct-30-19 04:05PM  
Oct-25-19 04:00PM  
Oct-15-19 08:00AM  
Sep-18-19 09:00AM  
Sep-03-19 08:55AM  
Aug-12-19 04:03PM  
Aug-08-19 08:00AM  
Jul-23-19 04:03PM  
Jul-19-19 04:00PM  
Jul-17-19 01:44PM  
Jun-24-19 08:00AM  
Jun-14-19 04:02PM  
Jun-13-19 04:02PM  
May-24-19 02:39PM  
May-23-19 06:38PM  
May-15-19 04:00PM  
May-02-19 04:00PM  
Apr-30-19 04:00PM  
Apr-25-19 10:33AM  
Apr-03-19 03:17PM  
Mar-26-19 04:00PM  
Mar-18-19 08:00AM  
Mar-14-19 08:00AM  
Feb-20-19 09:26AM  
Feb-19-19 08:00AM  
Jan-21-19 07:37AM  
Dec-21-18 11:26AM  
Dec-18-18 08:00AM  
Dec-11-18 07:30AM  
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to place full thickness sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands; and Orbera Coach, a digital and remotely delivered aftercare program. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Brazil, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pacitti DavidDirectorMay 19Sale6.8718,742128,8390May 20 05:50 PM
Gagnon Neil10% OwnerApr 05Buy5.483031,661402,580Apr 13 04:05 PM
BARR JOHN RDirectorMar 10Buy5.8910,00058,92925,970Mar 12 05:44 PM
Gagnon Neil10% OwnerFeb 23Buy4.624,16619,23026,446Feb 24 04:06 PM
Gagnon Neil10% OwnerFeb 23Buy4.628,05537,182402,277Feb 24 04:06 PM
Gagnon Neil10% OwnerFeb 22Buy4.8010,10348,524394,222Feb 24 04:06 PM
Gagnon Neil10% OwnerFeb 18Buy4.753781,79522,280Feb 22 04:06 PM
Gagnon Neil10% OwnerFeb 18Buy4.751,6497,830384,119Feb 22 04:06 PM
Gagnon Neil10% OwnerFeb 05Buy5.0522,589113,974116,360Feb 08 05:13 PM
Gagnon Neil10% OwnerFeb 05Buy4.7130,954145,861382,470Feb 08 05:13 PM
Gagnon Neil10% OwnerFeb 04Buy4.719,72945,845100,872Feb 05 04:31 PM
Gagnon Neil10% OwnerFeb 03Buy4.4628,388126,57991,143Feb 05 04:31 PM
Gagnon Neil10% OwnerFeb 02Buy4.4210,87348,05862,900Feb 03 04:05 PM
Gagnon Neil10% OwnerFeb 01Buy4.204731,988351,516Feb 03 04:05 PM